Amgen (AMGN) call put ratio 1.75 calls to 1 put into Q4
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Amgen (AMGN) PT Raised to $205 at Bernstein Following 4Q
February 2, 2018 8:06 AM ESTBernstein raised its price target on Amgen (NASDAQ: AMGN) to $205.00 (from $189.00) while maintaining a Market Perform rating following the company's 4Q earnings report. Amgen missed a bit on top line with a bit more of a material miss on EPS ($5,602, -0.7%; $2.89, -14c). The... More
